The tumor suppressor p53 is regulated in part by binding to cellular proteins. We used p53 as bait in the yeast two-hybrid system and isolated homeodomain-interacting protein kinase 1 (HIPK1) as a p53-binding protein. Deletion analysis showed that amino acids 100 -370 of p53 and amino acids 885-1093 of HIPK1 were sufficient for HIPK1-p53 interaction. HIPK1 was capable of autophosphorylation and specific serine phosphorylation of p53. The HIPK1 gene was highly expressed in human breast cancer cell lines and oncogenically transformed mouse embryonic fibroblasts. HIPK1 was localized to human chromosome band 1p13, a site frequently altered in cancers. Gene-targeted HIPK1؊͞؊ mice were grossly normal but oncogenically transformed HIPK1 ؊͞؊ mouse embryonic fibroblasts exhibited reduced transcription of Mdm2 and were more susceptible than transformed HIPK1؉͞؉ cells to apoptosis induced by DNA damage. Carcinogen-treated HIPK1 ؊͞؊ mice developed fewer and smaller skin tumors than HIPK1؉͞؉ mice. HIPK1 may thus play a role in tumorigenesis, perhaps by means of the regulation of p53 and͞or Mdm2. T he most frequently mutated gene associated with human cancers is p53 (1, 2). In response to cellular stresses such as DNA damage and oncogene expression, p53 promotes cell-cycle arrest or apoptosis (3, 4). p53 stabilization and activity are regulated by conformational changes (3) and posttranslational modification by phosphorylation (5). However, the kinase(s) relevant for phosphorylation of p53 in vivo remain obscure. p53 activity is also regulated by interaction with cellular molecules such as the oncogenic protein Mdm2 (2). Overexpression of Mdm-2 in certain tumors results in the inactivation and degradation of p53 (6-10). We set out to identify proteins that interact with p53 and to examine the expression of these molecules in transformed cells. We isolated the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1), previously identified as a homeodomain-interacting protein (11), and analyzed p53-HIPK1 interaction by various means. The physiological functions of HIPK1 were characterized by using gene-targeted HIPK1-deficient mice. Our in vivo and in vitro characterizations of HIPK1 suggest that HIPK1 is a modulator of p53 activity that can promote oncogenesis.
MethodsYeast Two-Hybrid Screening. A human p53 cDNA (amino acids 71-393; ref. 12) was subcloned in-frame into pGBT9 (GAL4 DNA-binding domain vector) and used to screen cDNA libraries constructed by using pGAD424 (GAL4-activation-domain plasmid; ref. 13) in yeast Y2H strain SFY526. The libraries were derived from rat embryo fibroblasts transformed with E1A ϩ Ras ϩ mutant p53 R273H, and a breast cancer cell line. -Galactosidase activities were measured by using the GalactoLight reporter assay kit (Tropix, Bedford, MA). The cDNA plasmids from -galactosidase-positive yeast were rescued, retested in yeast, and sequenced.Interaction of HIPK1 with p53 in 293 Cells. The SalI͞NotI HIPK1 fragment corresponding to amino acids 678-1149 was ligated in-frame with either ...